Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) currently has a daily average trading volume of 1.88M but it saw 1502389 shares traded in last market. With a market cap of 2.31B USD, the company’s current market price of $16.74 came rising about 0.78 while comparing to the previous closing price of $16.61. In past 52 weeks, the stock remained buoying in the range of price level as high as $30.41 and as low as $9.57.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Goldman which initiated the stock as “Neutral” in its note to investors issued on June 05, 2024, recommending a price target of $31 for it. Citigroup also issued its recommendations for the stock as it initiated the price target for the stock is $33.
Over the week, ARWR’s stock price is moving 7.58% up while it is 19.74% when we observe its performance for the past one month. Year-to-date it is -10.96% down and over the past year, the stock is showing a downside performance of -27.06%.
The company is expected to be releasing its next quarterly report in July, for which analysts forecasted an EPS of -1.1 while estimate for next year EPS is -0.18. In next quarter, company is expected to be making quarterly sales of $104.6M as analysts are expecting the sales for current fiscal year at $695.31M and seeing the company making $285.94M in sales next year. Moreover, analysts are in estimates of $29.01M for current-quarter revenue.
Currently, Arrowhead Pharmaceuticals Inc’s total number of outstanding shares is 138.06M with 13.02% of that held by the insiders while 77.24% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -10.65% and return on equity (ROE) at -24.67%. Stock’s beta reads 0.95. Stock has a price to book (P/B) ratio of 3.38 while price to sale or P/S ratio amounts to 4.24. Its return on asset (ROA) is -11.39% on average.
